忘情谷 › 深度行研 › 创新药周报：Rybrevant数据优异，看好EGFRcMET双抗市场前景

admin 发表于 2022-8-5 13:54:46

创新药周报：Rybrevant数据优异，看好EGFRcMET双抗市场前景

https://www.cnxiongqi.com/data/attachment/forum/202208/02/091449q11iixeyyibtoxii.png

查看完整版本: 创新药周报：Rybrevant数据优异，看好EGFRcMET双抗市场前景